Zeinab Choucair serves as the Executive Director of Medical affairs for ASCEND Therapeutics US, LLC, a role she has held since 2022.  Dr. Choucair is responsible for medical affairs strategy, medical affairs operations, and overseeing all Pharmacovigilance activities and KOL interactions. Dr. Choucair has a background in working with startups and global pharmaceuticals companies where she used her experience in medicine, science, and technology to drive the healthcare and clinical industries forward. Dr. Choucair received her MD from Avalon University School of Medicine, her MBA in Healthcare Management from Florida Institute of Technology, her BS in Chemistry from Wagner College, and is a certified Clinical Research Associate (CRA).